403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Avant Technologies Inc
(MENAFN- Baystreet) 09:50 AM EST - Avant Technologies Inc: Today announced the official launch of their joint venture, Klothonova LLC, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for innovative cell-based therapies to combat age-related diseases such as Alzheimer's and cancer, while also advancing anti-aging and longevity treatments. Avant Technologies Inc
shares O are trading unchanged at $0.39.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Reseach
- B2PRIME Strengthens Institutional Team's Growth With Appointment Of Lee Shmuel Goldfarb, Formerly Of Edgewater Markets
- BTCC Exchange Scores Big In TOKEN2049 With Interactive Basketball Booth And Viral Mascot Nakamon
- Ares Joins The Borderless.Xyz Network, Expanding Stablecoin Coverage Across South And Central America
- Primexbt Launches Stock Trading On Metatrader 5
- Solana's First Meta DEX Aggregator Titan Soft-Launches Platform
- Moonacy Protocol Will Sponsor And Participate In Blockchain Life 2025 In Dubai
- Primexbt Launches Instant Crypto-To-USD Exchange
More Story
Comments
No comment